Fixed Income

AXA Global Strategic Bond Fund: Macro risks decline but lockdowns persist

  • 18 January 2021
  • 5min read

Key points

  • Vaccine rollout begins but surge in global virus cases curtails opening of economies
  • UK 10-year gilt yields moved 11bps lower during the month, closing at 0.20%
  • We reduced government bond exposure in favour of credit opportunities

What’s happening?

UK 10-year gilt yields moved lower during the month, outperforming US and German equivalents.

Despite rising virus cases, further restrictions in Europe and uncertainty around the Brexit deadline, risk markets rallied as they took confidence from the start of the vaccine rollout and an increasingly isolated Donald Trump.

With monetary stimulus plentiful, very low government bond yields and no sign of higher official interest rates across the world, December again saw large inflows across various capital markets, which drove valuations higher.

Portfolio positioning and performance

Defensive (41%): we reduced government bond exposure during the month, finding better opportunities in credit. Duration exposure came back down to 5 years, still preferring US duration, although we recently added to German duration which outperformed US over the month.

Intermediate (24%): we added to US credit exposure during the month, topping up a broad diversified pool of higher quality credit. We continue to prefer BBB assets as high quality, at times long duration AA / A credit, already prices in much good news.

Aggressive (35%): we increased exposure to US high yield during the month, with exposure near 20% the highest for many months, to benefit from further credit tightening as the “hunt for yield” trade looks set to continue in 2021.

Outlook

2020 has been an extraordinary year, but as it comes to a close, the strength in credit and high yield markets is in stark contrast to the events of the first quarter of the year.  

Such is the strength in central bank support that markets are prepared to look through further lock down restrictions and a slower recovery, to give the economic recovery the benefit of the doubt.

Looking ahead to 2021, it should be the year that we focus on the positive vaccine developments and unlocking of virus related restrictions, even if in the first few months the attention will be on further lockdowns.

No assurance can be given that the AXA Global Strategic Bond Fund will be successful. Investors can lose some or all of their capital invested. The AXA Global Strategic Bond Fund is subject to risks including counterparty risk, derivatives risk, geopolitical risk, interest rate risk, securitised assets or CDO assets risk, emerging market risk, liquidity risk, credit risk, risks linked to investments in sovereign debt, high yield bonds risk and contingent convertible bonds (“CoCos”) risk. Further explanation of the risks associated with an investment in this fund can be found in the prospectus.

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This promotional communication does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee that forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.